Published in Lancet on August 02, 1986
Practical diagnostic testing for human immunodeficiency virus. Clin Microbiol Rev (1988) 1.61
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. J Clin Microbiol (1987) 1.49
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis. J Clin Microbiol (1989) 1.36
Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol (1988) 1.15
Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting. J Clin Microbiol (1988) 1.08
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. J Clin Microbiol (1988) 0.96
Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections. J Clin Microbiol (1988) 0.94
Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis. J Clin Microbiol (1988) 0.90
New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay. J Clin Microbiol (1990) 0.87
Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes. J Clin Microbiol (1989) 0.87
Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening. J Clin Microbiol (1989) 0.87
Laboratory tests for detection of human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (1995) 0.86
Serological diagnosis of HIV infection: incidence, outcome and significance of partial reactions found in western blot analysis. Clin Exp Immunol (1989) 0.82
Antigen-antibody reaction in solution in capture competition immunoassay for human immunodeficiency virus antibodies. J Clin Microbiol (1989) 0.79
Origin of HIV. BMJ (1989) 0.79
An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens. Int J Med Sci (2004) 0.77
False-positive results of confirmatory testing for antibody to HIV-I. CMAJ (1987) 0.76
Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology. J Clin Microbiol (1991) 0.75
Comparative evaluation of particle agglutination test for antibody to human immunodeficiency virus. Genitourin Med (1988) 0.75
Evaluation of the Genetic Systems Corp. Integra HIV-1 Pageblot system. J Clin Microbiol (1992) 0.75
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol (1970) 3.84
Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol (1984) 3.70
Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool. J Med Virol (1983) 3.39
Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol (1984) 3.32
Detection of adenoviruses and enteroviruses in polluted waters by nested PCR amplification. Appl Environ Microbiol (1994) 3.07
Polymerase chain reaction for detection of adenoviruses in stool samples. J Clin Microbiol (1990) 3.00
Genetic variability of adenoviruses. Ann N Y Acad Sci (1980) 2.91
HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus (2000) 2.81
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79
Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J Clin Microbiol (2001) 2.77
Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76
Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol (2000) 2.38
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis (2005) 2.35
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
DNA restriction analysis of adenovirus prototypes 1 to 41. Arch Virol (1986) 2.20
Why has coeliac disease increased in Swedish children? Lancet (1994) 2.18
Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet (1974) 2.16
Detection of adenoviruses in stools from healthy persons and patients with diarrhea by two-step polymerase chain reaction. J Med Virol (1992) 2.16
Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis. Infect Immun (1980) 2.15
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis (1995) 1.94
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D. J Med Virol (1981) 1.88
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J Clin Microbiol (1997) 1.76
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J Virol (1990) 1.76
Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70
Analysis of 15 different genome types of adenovirus type 7 isolated on five continents. J Virol (1986) 1.69
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol (1992) 1.64
Molecular epidemiology of adenoviruses: global distribution of adenovirus 7 genome types. J Clin Microbiol (1985) 1.64
Epidemic outbreaks of adenovirus 7 with special reference to the pathogenicity of adenovirus genome type 7b. Am J Epidemiol (1980) 1.63
Two new serotypes of enteric adenovirus causing infantile diarrhoea. Dev Biol Stand (1983) 1.63
Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus. J Clin Microbiol (1976) 1.63
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis (1998) 1.61
Molecular epidemiology of adenovirus types 3 and 7 isolated from children with pneumonia in Beijing. J Med Virol (1996) 1.61
Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991-1994). J Med Virol (1996) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus alpha(v) integrins. J Virol (2000) 1.55
Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc Natl Acad Sci U S A (1988) 1.55
Epidemic acute diarrhoea in adults associated with infantile gastroenteritis virus. Lancet (1978) 1.55
Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54
Direct identification of enteric adenovirus, a candidate new serotype, associated with infantile gastroenteritis. J Clin Microbiol (1980) 1.54
Specific Puumala IgG virus half a century after haemorrhagic fever with renal syndrome. Lancet (1991) 1.53
O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins. Arch Virol (1981) 1.53
The mixed haemadsorption test as an aid to the diagnosis of thyroid autoimmune disease. Clin Exp Immunol (1968) 1.52
High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med (1999) 1.49
Molecular epidemiology of rotavirus infections in Uppsala, Sweden, 1981: disappearance of a predominant electropherotype. J Med Virol (1986) 1.49
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48
Molecular epidemiology of adenoviruses: alternating appearance of two different genome types of adenovirus 7 during epidemic outbreaks in Europe from 1958 to 1980. Infect Immun (1981) 1.48
Fiber genes of adenoviruses with tropism for the eye and the genital tract. Virology (1997) 1.48
Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J (1989) 1.48
Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care (1999) 1.46
Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect (1994) 1.45
Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods (2003) 1.45
Comparison of 17 genome types of adenovirus type 3 identified among strains recovered from six continents. J Clin Microbiol (1988) 1.45
Intradermal vs intramuscular hepatitis B vaccinations. JAMA (1990) 1.43
Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect (2010) 1.42
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology (2004) 1.40
Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species. J Virol (1985) 1.39
Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods (1998) 1.39
Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol (1985) 1.39
Demonstration of three different subtypes of adenovirus type 7 by DNA restriction site mapping. Infect Immun (1978) 1.38
T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun (1983) 1.37
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37
Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses (1996) 1.36
Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36
Treatment of infantile atopic dermatitis with a strict elimination diet. Clin Allergy (1978) 1.34
Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.34
Sequence analysis of the E3 region and fiber gene of human adenovirus genome type 7h. Virology (1996) 1.33
Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol (1992) 1.33
Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol (1999) 1.32
Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS (1997) 1.31
Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer (2007) 1.30
Immunological changes in primary HIV-1 infection. AIDS (1990) 1.30
Genetic relationship between thirteen genome types of adenovirus 11, 34, and 35 with different tropisms. Intervirology (1991) 1.28
Classification of human adenoviruses by SDS-polyacrylamide gel electrophoresis of structural polypeptides. Intervirology (1979) 1.28
Preparation of specific antisera against adenoviruses by affinity bead immunization (ABI). J Immunol Methods (1979) 1.28